Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Novel Formulation Strategies

Rajiv Nayar's Biography

Rajiv Nayar, CEO, HTD Biosystems Inc.

Dr. Nayar received his Ph.D. in Biochemistry from University of British Columbia, B.C. He was head of the Formulation and Drug Delivery Unit at Bayer Corp. Biotechnology Division from 1991 until 2000. He is President and Founder of HTD Biosystems, Inc. He has published over 80 scientific articles and received 15 patents. Dr. Nayar is an adjunct Professor of Pharmaceutics and has expertise in areas of protein formulation, drug delivery, liposomes, vaccines, and immunotherapy approaches in oncology. He is also a certified course instructor in DOE.

Rajiv Nayar Image

Accelerating Formulation Development of Protein Drugs: Challenges and Opportunities

Friday, 21 April 2017 at 09:30

Add to Calendar ▼2017-04-21 09:30:002017-04-21 10:30:00Europe/LondonAccelerating Formulation Development of Protein Drugs: Challenges and OpportunitiesNovel Formulation Strategies in

Add to Calendar ▼2017-04-20 00:00:002017-04-21 00:00:00Europe/LondonNovel Formulation StrategiesNovel Formulation Strategies in